With regard to ride-hailing company Lyft’s reported attempts to seek a $9 billion buyout, unidentified sources familiar with the proceedings have told Bloomberg that Lyft’s bigger rival Uber is apparently interested in the acquisition.
However, as per the sources, Uber has already asserted that it would not pay more than $2 billion to acquire Lyft — a deal which evidently is below acceptable for Lyft, which is pushing a $9 billion asking price with prospective buyers like General Motors.
According to the sources, Uber has been mulling the takeover of Lyft since 2014. The possibility of Lyft’s acquisition by Uber was discussed by the two companies at an informal setting. But, because Uber is not keen on paying more than $2 billion for the acquisition, it has not yet pushed an official takeover offer.
Meanwhile, even though the acquisition of Lyft would help Uber expand its market share in the ride-hailing service market, Uber CEO Travis Kalanick and other top-rung company executives are doubtful that the acquisition would clear US antitrust laws.
Towards that end, Kalanick has purportedly said in a private meeting that even if Lyft accepts a $2 billion buyout deal, he would not be in favor of the acquisition because the merger of the two companies would face harsh scrutiny from US antitrust regulators.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas